Veracyte Inc (VCYT NASDAQ) stock market data APIs
$41.379
0.06(0.1%)
as of November 7, 2025
Try our APIs with
free plan!
Veracyte Inc Financial Data Overview
Price chart is built with
Anychart
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Prev. Close
41.379
Open
41.4352
High
41.9374
Low
40.1485
52 wk Range
22.61-47.3162
Market Cap
3 296 M
P/E Ratio
109.7369
Shares Outstanding
79 049 K
Revenue
495 M
EPS
0.51
Beta
1.86
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Veracyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Veracyte Inc data using free add-ons & libraries
Get Veracyte Inc Fundamental Data
Veracyte Inc Fundamental data includes:
- Net Revenue: 495 M
- EBITDA: 74 398 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: 0.3196
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Veracyte Inc News
New
Pediatrix Medical Q3 Earnings Beat Estimates on Declining Expenses
Pediatrix Medical Group, Inc. MD reported third-quarter 2025 adjusted earnings per share (EPS) of 67 cents, which surpassed the Zacks Consensus Estimate by 45.7%. The bottom line surged 52.3% year ove...
Veracyte (VCYT) Turns Profitable, But Significant $27M Loss Challenges Bullish Narratives
Veracyte (VCYT) recently moved into profitability, with its net profit margin turning positive even as a significant, non-recurring loss of $27.0 million affected the latest twelve-month results to Se...
Stocks making the biggest moves midday: Unity Software, Rivian, Pinterest, Trex & more
Check out the companies making the biggest moves midday: Unity Software — The video game company rallied 8% on better than-expected results for the third quarter. Unity's fourth-quarter revenue guid...
Stocks making the biggest moves premarket: AMD, Cava, Pinterest, Super Micro Computer and more
Check out the companies making headlines before the bell. Advanced Micro Devices — The semiconductor maker fell 5% after sharing adjusted margin guidance for its current quarter that was in line wit...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
